Open access · OA
via OpenAlex
The Presence of Alpha‐Synuclein in Skin from Melanoma and Patients with Parkinson's Disease
Ildefonso Rodríguez‐Leyva, Érika Chi-Ahumada, Manuel Mejía, Juan Pablo Castanedo-Cázares, William Eng, Sami Kameel Saikaly, Juan Carrizales-Rodríguez, Todd Levine, Robert A. Norman, María Esther Jiménez-Capdeville
Movement Disorders Clinical Practice · 2017 · ▲ 42 citations
Abstract
BACKGROUND: The misfolding and prion-like propagation of the protein α-synuclein (α-syn) is the leading molecular signature in Parkinson's disease (PD). There is a significant coincidence of PD and melanoma that may suggest a shared pathophysiology. This study compared the presence of α-syn in neural crest-derived tissues, such as nevi, melanoma, skin tags, and skin biopsies from patients with PD and healthy controls. METHODS: Biopsies from participants with PD were obtained from patients from a tertiary referral center for dermatology and neurology in Mexico and a private dermatopathology center in Florida between January 2015 and March 2016. Biopsies from 7 patients with melanoma, 15 with nevi, 9 with skin tags, 8 with PD, and 9 skin biopsies from healthy volunteers were analyzed for immunohistochemical determination of α-syn and tyrosinase. All analyses were performed by pathologists who were blinded with respect to the clinical diagnosis. RESULTS: In healthy controls, positive α-syn status was restricted to scattered cells in the basal layer of the epidermis and accounted for 1 ± 0.8% of the analyzed area. In patients with PD, there was increased staining for α-syn PD (3.3 ± 2.3%), with a higher percentage of positive cells in nevi (7.7 ± 5.5%) and melanoma (13.6 ± 3.5%). There was no increased staining in skin tags compared with healthy controls. CONCLUSION: Patients with PD and melanoma have increased staining for α-syn in their skin. The authors propose that neurons and melanocytes, both derived from neuroectodermal cells, may share protein synthesis and regulation pathways that become dysfunctional in PD and melanoma.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/mdc3.12494
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Rodríguez‐Leyva, I., Chi-Ahumada, �., Mejía, M., Castanedo-Cázares, J.P., Eng, W., Saikaly, S.K., Carrizales-Rodríguez, J., Levine, T., Norman, R.A., & Jiménez-Capdeville, M.E. (2017). The Presence of Alpha‐Synuclein in Skin from Melanoma and Patients with Parkinson's Disease. <em>Movement Disorders Clinical Practice</em>. https://doi.org/10.1002/mdc3.12494
Vancouver
Rodríguez‐Leyva I, Chi-Ahumada �, Mejía M, Castanedo-Cázares JP, Eng W, Saikaly SK, et al. The Presence of Alpha‐Synuclein in Skin from Melanoma and Patients with Parkinson's Disease. Movement Disorders Clinical Practice. 2017. doi:10.1002/mdc3.12494.
BibTeX
@article{ildefonso2017ThePre,
title = {The Presence of Alpha‐Synuclein in Skin from Melanoma and Patients with Parkinson's Disease},
author = {Ildefonso Rodríguez‐Leyva and Érika Chi-Ahumada and Manuel Mejía and Juan Pablo Castanedo-Cázares and William Eng and Sami Kameel Saikaly and Juan Carrizales-Rodríguez and Todd Levine and Robert A. Norman and María Esther Jiménez-Capdeville},
journal = {Movement Disorders Clinical Practice},
year = {2017},
doi = {10.1002/mdc3.12494},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Parkinson s Disease 2020
Preprint · OA
Alpha-Synuclein Protofibrils in Cerebrospinal Fluid: A Potential Biomarker for Parkinson's Disease
Neurology Research International 2025
Open access · CC-BY
Nuclear Alpha‐Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
Neuropathology and Applied Neurobiology 2018
Open access · CC-BY
Detection of alpha‐synuclein conformational variants from gastro‐intestinal biopsy tissue as a potential biomarker for Parkinson's disease
Scientific Reports 2025
Open access · CC-BY
Alpha-synuclein is increased in erythrocytes in parkinson’s disease cases
Frontiers in Cellular Neuroscience 2018
Open access · CC-BY
Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease
Parkinsonism & Related Disorders 2022
Open access · CC-BY